McKesson Corporation (MCK) to Issue Quarterly Dividend of $0.94 on January 4th

McKesson Corporation (NYSE:MCK) declared a quarterly dividend on Tuesday, October 20th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.94 per share on Monday, January 4th. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, December 1st.

McKesson has raised its dividend by an average of 0.1% per year over the last three years and has increased its dividend annually for the last 17 consecutive years. McKesson has a payout ratio of 9.0% meaning its dividend is sufficiently covered by earnings. Analysts expect McKesson to earn $49.99 per share next year, which means the company should continue to be able to cover its $3.76 annual dividend with an expected future payout ratio of 7.5%.

McKesson Trading Down 1.5%

Shares of McKesson stock opened at $1,014.79 on Thursday. McKesson has a twelve month low of $723.68 and a twelve month high of $1,030.27. The firm’s 50-day moving average price is $905.65 and its 200 day moving average price is $840.38. The firm has a market capitalization of $118.31 billion, a PE ratio of 27.16, a P/E/G ratio of 2.05 and a beta of 0.30.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating analysts’ consensus estimates of $9.56 by $0.37. The business had revenue of $105.38 billion during the quarter, compared to analysts’ expectations of $103.88 billion. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business earned $8.26 earnings per share. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, sell-side analysts predict that McKesson will post 44.71 EPS for the current fiscal year.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: UBS raised its price target for McKesson to $1,200, signaling continued confidence in the company’s earnings outlook and potential upside. UBS raises McKesson price target
• Positive Sentiment: Mizuho increased its McKesson price target to $1,020 from $905. The move follows the stock’s strong performance and reflects improved expectations, although the firm maintained a neutral rating. Mizuho raises McKesson price target
• Positive Sentiment: McKesson reached a new one-year high following an analyst upgrade, reinforcing strong market momentum. McKesson reaches new one-year high
• Neutral Sentiment: The company declared a regular quarterly dividend of $0.94 per share, payable January 4, 2027, to shareholders of record December 1. The dividend supports shareholder returns, but its annualized yield is only about 0.4%. McKesson declares quarterly dividend
• Neutral Sentiment: Recent coverage noted McKesson had outperformed the broader market before the latest pullback, suggesting the decline may reflect consolidation after a substantial run rather than a new fundamental deterioration. McKesson outperforms broader market
• Negative Sentiment: Insider Francisco Fraga sold 800 shares, which may create a modest perception of reduced insider conviction, although the transaction is small relative to McKesson’s market value. McKesson insider share sale
• Negative Sentiment: Separate commentary about a McKesson-related security incident raises potential enterprise cybersecurity concerns. Any confirmed breach, remediation costs, or operational disruption could weigh on investor sentiment. McKesson cybersecurity commentary

McKesson Company Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.